RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/36044856http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/36044856http://www.w3.org/2000/01/rdf-schema#comment"The Hippo tumor-suppressor pathway is frequently dysregulated in human cancers and represents a therapeutic target. However, strategies targeting the mammalian Hippo pathway are limited because of the lack of a well-established cell-surface regulator. Here, we show that transmembrane protein KIRREL1, by interacting with both SAV1 and LATS1/2, promotes LATS1/2 activation by MST1/2 (Hippo kinases), and LATS1/2 activation, in turn, inhibits activity of YAP/TAZ oncoproteins. Conversely, YAP/TAZ directly induce the expression of KIRREL1 in a TEAD1-4-dependent manner. Indeed, KIRREL1 expression positively correlates with canonical YAP/TAZ target gene expression in clinical tumor specimens and predicts poor prognosis. Moreover, transgenic expression of KIRREL1 effectively blocks tumorigenesis in a mouse intrahepatic cholangiocarcinoma model, indicating a tumor-suppressor role of KIRREL1. Hence, KIRREL1 constitutes a negative feedback mechanism regulating the Hippo pathway and serves as a cell-surface marker and potential drug target in cancers with YAP/TAZ dependency."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.org/dc/terms/identifier"doi:10.1016/j.celrep.2022.111296"xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"He C."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Gu Y."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Li J."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Sun Y."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Wang Y."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Wang X."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Zhu Y."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Yu A."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Sha Z."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Zhong Z."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Lan F."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/author"Yu F.X."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/date"2022"xsd:gYear
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/name"Cell Rep"xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/pages"111296"xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/title"Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers."xsd:string
http://purl.uniprot.org/citations/36044856http://purl.uniprot.org/core/volume"40"xsd:string
http://purl.uniprot.org/citations/36044856http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/36044856
http://purl.uniprot.org/citations/36044856http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/36044856
http://purl.uniprot.org/uniprot/#_B4DN67-mappedCitation-36044856http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36044856
http://purl.uniprot.org/uniprot/#_B4E2Y3-mappedCitation-36044856http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36044856
http://purl.uniprot.org/uniprot/#_P46937-mappedCitation-36044856http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36044856